Stephen Kilmer
Investor Relations
Replay available
BioRestorative Therapies, Inc. (BRTX) Q4 2024 Earnings Call
BioRestorative Therapies, Inc. (NASDAQ: BRTX) Q4 2024 earnings conference call, held 2025-03-27. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Lance Allstatt
Chairman & Chief Executive Officer
Rob Crystal
Chief Financial Officer
Francisco Silva
Vice President of Research and Development
Michael Okunowicz
Analyst, The Maxim Group
Elema Piros
Analyst, Rodman & Renshaw
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Biorestorative Therapies, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.820 Good afternoon, everyone, and welcome to the Bio-Restorative Therapies 2024 00:00:05.820 -- 00:00:11.468 Results Conference Call. At this time, all participants are in a listen-only 00:00:11.468 -- 00:00:16.476 mode, and if anyone should require operator assistance during this conference, please 00:00:16.476 -- 00:00:21.724 press star zero on your phone keypad. Please note, this conference is being recorded. 00:00:21.724 -- 00:00:27.412 I will now turn the conference over to your host, Stephen Kilmer, Investor Relations. 00:00:27.412 -- 00:00:30.414 Sir, the floor is yours. 00:00:30.727 -- 00:00:33.591 Thank you, Jenny. Good afternoon, everyone. 00:00:33.591 -- 00:00:37.696 Let me start by pointing out that this conference call will include forward-looking statements 00:00:37.696 -- 00:00:42.860 within the meaning of the Private Securities Litigation Reform Act of 1995. 00:00:43.003 -- 00:00:47.048 All forward-looking statements are based on biorestorative therapy's current beliefs, 00:00:47.048 -- 00:00:49.311 assumptions, and expectations, 00:00:49.311 -- 00:00:53.657 and such statements involve known and unknown risks, uncertainties, and other factors 00:00:53.657 -- 00:00:58.023 that may cause actual results, performance, or achievements to be materially different 00:00:58.023 -- 00:01:00.680 from those implied by such statements. 00:01:00.680 -- 00:01:03.544 no forward-looking statement can be guaranteed. 00:01:03.544 -- 00:01:08.870 For details on factors, among others, that could affect expectations, see Part 1, 00:01:08.870 -- 00:01:14.956 Item 1A of our annual report on Form 10-K for the year ended December 31st, 2024, 00:01:15.659 -- 00:01:19.864 which will be filed with the Securities and Exchange Commission. 00:01:19.86...